spacer
home > epc > winter 2003 > e-meetings and e-learning - how the internet can be harnessed to achieve efficiencies in clinical drug development
PUBLICATIONS
European Pharmaceutical Contractor

e-Meetings and e-Learning - How the Internet can be Harnessed to Achieve Efficiencies in Clinical Drug Development

Driven by a need to reduce drug development costs and speed new drugs to market in the most efficient manner possible, today's pharma industry is awash with cost containment measures. Senior executives continue the search for elusive efficiencies, ranging from the overnight closure of departments that were previously considered integral to a company's success to the imposition of strict new travel policies.

Few pharmaceutical companies or contract research organisations can have been immune to cost cutting in recent years and many have looked to the promise of technology to help them achieve their goals. Unfortunately, many technological advances require expensive re-engineering of traditional drug development processes, and while the long-term benefits of for example, electronic data capture (EDC) are likely to be sizeable, even when outsourced to a niche provider, EDC requires significant upfront investment in hardware and software as well as time-consuming re-writing of processes and associated training. A more modest approach involves combining readily available technology with small changes in process to produce an immediate impact on operational performance without the need for investment. When such small steps are applied consistently across an organisation, the benefits can be surprising.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jane Baguley, Director at Cornaxis Ltd

With an Honours degree in Cell Sciences, Jane Baguley joined the pharmaceutical industry in 1988. After five years with Yamanouchi Pharma, Jane began a varied career at Quintiles encompassing both operational and business roles including clinical project management, medical writing, communication and strategy and business management. At the beginning of 2002, Jane set up Cornaxis Ltd to provide consultancy, strategic and operational services to the pharma industry. Cornaxis focuses on the use of novel technologies to support the attainment of cost efficiencies in the drug development process, while Jane maintains a particular interest in the challenge of patient recruitment.

spacer
Jane Baguley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Irelandís premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement